CMAB vs IMAB in Metastatic Prostate Cancer

Clinical trial NCT00255268 · WITHDRAWN

Trial details

NCT number: NCT00255268
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2004-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.